Group One Trading
JAZZ icon

Group One Trading’s Jazz Pharmaceuticals JAZZ Stock Holding History

Group One Trading’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$662K Hold
3,500
– – ﹤0.01% 3079
2025
Q4 		$595K Buy
3,500
+3,100
+775% +$475K ﹤0.01% 3333
2025
Q3 		$52.7K Buy
+400
New +$48K ﹤0.01% 5918
2025
Q2 		– Sell
-3,600
Closed -$447K – 8279
2025
Q1 		$447K Buy
3,600
+2,900
+414% +$378K ﹤0.01% 3210
2024
Q4 		$86.2K Sell
700
-5,900
-89% -$695K ﹤0.01% 4634
2024
Q3 		$735K Buy
6,600
+2,300
+53% +$252K ﹤0.01% 2561
2024
Q2 		$459K Buy
4,300
+300
+8% +$33K ﹤0.01% 2645
2024
Q1 		$482K Sell
4,000
-600
-13% -$73.5K ﹤0.01% 2767
2023
Q4 		$566K Hold
4,600
– – ﹤0.01% 2957
2023
Q3 		$595K Buy
4,600
+4,500
+4,500% +$600K ﹤0.01% 2738
2023
Q2 		$12.4K Buy
+100
New +$13.5K ﹤0.01% 6275
2023
Q1 		– Sell
-46,100
Closed -$7.34M – 7562
2022
Q4 		$7.34M Sell
46,100
-5,900
-11% -$865K 0.02% 920
2022
Q3 		$6.93M Hold
52,000
– – 0.01% 938
2022
Q2 		$8.11M Sell
52,000
-3,000
-5% -$462K 0.01% 983
2022
Q1 		$8.56M Sell
55,000
-55,500
-50% -$8.05M 0.01% 1108
2021
Q4 		$14.1M Buy
110,500
+600
+0.5% +$78.9K 0.01% 868
2021
Q3 		$14.3M Sell
109,900
-16,900
-13% -$2.55M 0.02% 814
2021
Q2 		$22.5M Buy
126,800
+126,600
+63,300% +$21.9M 0.03% 561
2021
Q1 		$33K Sell
200
-83,100
-100% -$13.7M ﹤0.01% 6487
2020
Q4 		$13.7M Buy
83,300
+74,200
+815% +$11.1M 0.02% 625
2020
Q3 		$1.3M Buy
9,100
+6,600
+264% +$818K ﹤0.01% 1957
2020
Q2 		$276K Hold
2,500
– – ﹤0.01% 3123
2020
Q1 		$249K Sell
2,500
-12,400
-83% -$1.6M ﹤0.01% 2580
2019
Q4 		$2.22M Sell
14,900
-7,400
-33% -$1.01M 0.02% 1212
2019
Q3 		$2.86M Buy
22,300
+13,900
+165% +$1.86M 0.02% 940
2019
Q2 		$1.2M Sell
8,400
-7,400
-47% -$994K 0.01% 1475
2019
Q1 		$2.26M Buy
15,800
+11,000
+229% +$1.43M 0.03% 853
2018
Q4 		$595K Sell
4,800
-7,200
-60% -$1.07M 0.01% 1886
2018
Q3 		$2.02M Sell
12,000
-9,700
-45% -$1.67M 0.02% 1155
2018
Q2 		$3.74M Buy
21,700
+18,600
+600% +$3.04M 0.03% 703
2018
Q1 		$468K Sell
3,100
-52,500
-94% -$7.7M ﹤0.01% 2114
2017
Q4 		$7.49M Buy
55,600
+41,000
+281% +$5.69M 0.05% 436
2017
Q3 		$2.13M Sell
14,600
-2,600
-15% -$393K 0.02% 1004
2017
Q2 		$2.67M Sell
17,200
-12,800
-43% -$1.96M 0.03% 783
2017
Q1 		$4.35M Buy
30,000
+4,300
+17% +$560K 0.05% 466
2016
Q4 		$2.8M Sell
25,700
-36,200
-58% -$4.03M 0.03% 732
2016
Q3 		$7.52M Buy
61,900
+43,700
+240% +$5.89M 0.08% 269
2016
Q2 		$2.57M Sell
18,200
-30,200
-62% -$4.45M 0.03% 674
2016
Q1 		$6.32M Buy
48,400
+24,200
+100% +$3.01M 0.09% 264
2015
Q4 		$3.4M Sell
24,200
-3,200
-12% -$443K 0.04% 551
2015
Q3 		$3.64M Buy
27,400
+13,100
+92% +$2.26M 0.05% 474
2015
Q2 		$2.52M Sell
14,300
-12,800
-47% -$2.3M 0.04% 611
2015
Q1 		$4.68M Sell
27,100
-96,400
-78% -$16.5M 0.07% 276
2014
Q4 		$20.2M Sell
123,500
-31,500
-20% -$5.23M 0.31% 44
2014
Q3 		$24.9M Buy
155,000
+28,500
+23% +$4.38M 0.38% 29
2014
Q2 		$18.6M Buy
126,500
+17,100
+16% +$2.37M 0.29% 45
2014
Q1 		$15.2M Buy
109,400
+25,000
+30% +$3.76M 0.26% 60
2013
Q4 		$10.7M Buy
84,400
+33,600
+66% +$3.48M 0.16% 99
2013
Q3 		$4.67M Sell
50,800
-22,700
-31% -$1.83M 0.09% 228
2013
Q2 		$5.05M Buy
+73,500
New +$4.49M 0.12% 154

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Group One Trading's JAZZ Position: Q1 2026 in Review

Group One Trading sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 6,815 shares — an estimated $1.19M sold.

Group One Trading first reported a position in JAZZ in Q2 2013 and held it in 31 quarters. The position peaked at $11.2M in Q3 2014. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Group One Trading reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 6,815 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.19M.
  • Group One Trading first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 31 quarters.
  • Group One Trading's Jazz Pharmaceuticals position peaked at $11.2M in Q3 2014.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.